Skip to main content

GNVR · Genvor Inc · Financials

Track GNVR — free
$0.62 At close · Oct 19
Market Cap
$24.85M
Shares
36.41M
Volume · Oct 19 100 Avg daily vol (3M) 3763

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$0
FY2022 Revenue FY2019–FY2022
Net Income
-$5.59M -93.7%
FY2025 Net Income FY2019–FY2025
Diluted EPS
-$0.22 -46.7%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-$555.72K +43%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$0 — — — $0 $0 $0 $0
— — — — -$102.79K — — —
$386.2K $455.9K $240.26K $0 $0 — — —
$45.57K — — — — $23.82K $4870 $6000
— — — — $1832 — — —
$4.01M $6.41M $2.78M $1.44M $3.1M $23.82K $4870 $6000
-$4.01M -$6.41M -$2.78M -$1.44M -$3.1M — — —
— — — — -$3.1M — — —
$107.96K $59.81K $17.69K $43.8K $102.79K — — —
$556.66K $820.81K -$101.91K -$268.8K -$337.62K — — —
-$3.45M -$5.59M -$2.88M -$1.71M — — — —
— — — — $0 — — —
-$3.45M -$5.59M -$2.88M -$1.71M -$3.44M -$23.82K -$4870 -$6000
— — — — -$3.44M — — —
USD/shares — — -$0.15 -$0.07 -$0.15 — — —
USD/shares -$0.06 -$0.22 -$0.15 -$0.07 -$0.15 — — —
shares — — 19.88M 19.55M 22.49M 20M 20M 20M
shares — 25.7M 19.88M 19.55M 22.49M 20M 20M 20M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of convertible notes payable 2026-06-30 USD 317,189 10-Q filed 2026-08-14
Current portion of loans payable 2026-06-30 USD 48,750 10-Q filed 2026-08-14
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Agricultural Inputs median 1.44×
EV/EBIT
—
Agricultural Inputs median 9.29×
P/E (TTM)
—
Agricultural Inputs median 8.80×
Key facts CIK 1792941 CUSIP 37254K100 Visit website